Status: Phase I/IIa study in preparation
Licensed to Sanofi: Phase II ongoing
Status: Pre–Clinical complete
Status: Phase I trial complete
Gene therapy for Usher syndrome type 1B
Licensed to Sanofi: Phase I/IIa trial ongoing
This is a partner's product, where Oxford Biomedica provide process development and bioprocessing.